MS Industrie AG
MSAG.DE News Today: Stay Updated with the Latest MS Industrie AG News in Real Time
Find MSAG.DE news now at Meyka AI. Stay informed with the latest MS Industrie AG stocks updates, including price news, market analysis, and expert insights.
Festo Cuts 1,300 Jobs on May 9: German Automation Giant Faces Asian Competition
Festo cuts 1,300 German jobs amid Asian competition and weak demand, launching global transformation to streamline costs and adapt to market changes.
Siemens Healthineers Stock May 7: Diagnostics Spinoff Plan
Siemens Healthineers stock drops 4.61% as company plans diagnostics spinoff and cuts guidance. Explore strategic implications for investors.
Bayer Stock May 7: $2.45B Perfuse Deal Signals Pharma Shift
Bayer acquires Perfuse Therapeutics for $2.45B to strengthen ophthalmology portfolio with PER-001 drug candidate, addressing Eylea patent risks.
VW Stock April 26: Blume’s Restructuring Plan Faces Political Pushback
Oliver Blume’s VW restructuring plan faces political resistance from Lower Saxony over factory closures. Key board decision April 26.
Jungheinrich Stock April 25: Profit Collapse Triggers Analyst Downgrade
Jungheinrich stock plunges as Q1 profit halves. Russia withdrawal, strikes, and weak demand pressure earnings. Bernstein downgrades to €46 target.
TUI Stock April 23: Iran War Blocks Ships, Losses Mount
TUI stock crashes as Iran conflict blocks cruise ships. Death cross signals further decline amid travel industry disruption.
Erich Jaeger Insolvency April 17: German Auto Supplier Collapses
Erich Jaeger GmbH files for insolvency after 90 years, affecting 1,000 workers. German auto supplier collapse deepens automotive supply chain crisis.
Humanoid Robots April 16: $4 Trillion Market Reshapes Industry
Humanoid robots market surges 1,000% on April 16. Roland Berger forecasts $4 trillion opportunity. Tesla pivots to Optimus production.
BAYN.DE Stock Today: April 08 – Glyphosate Supreme Court Test Nears
Bayer stock today: shares steady as investors eye the April 27 glyphosate Supreme Court hearing and a $7.25B Missouri settlement. We cover risks, levels, and 2030 pharma targets.